Eplerenone Pharmacia

Research output: Contribution to journalReview ArticleResearchpeer-review

1 Citation (Scopus)


Pharmacia Corp (formerly GD Searle & Co) is developing eplerenone, an aldosterone receptor antagonist, as a potential treatment for congestive heart failure and systemic hypertension. The compound has been registered for hypertension and Pharmacia plans to submit a supplemental NDA for congestive heart failure in the first half of 2003 based on positive results from a phase III clinical trial.

Original languageEnglish
Pages (from-to)316-322
Number of pages7
JournalCurrent Opinion in Investigational Drugs
Issue number3
Publication statusPublished - 1 Mar 2003

Cite this